Indivior Wants Class Tossed From Suboxone Antitrust Case

By Piper Hudspeth Blackburn (May 11, 2023, 6:05 PM EDT) -- Indivior urged a Pennsylvania federal court on Thursday to dismiss a class of end payors from a case accusing the company of monopolizing the market for the opioid addiction treatment Suboxone, arguing the end payors have never demonstrated how they "suffered any harm" from the alleged violations....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!